All News about Aytu Biopharma Inc
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_4937.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_17446.jpeg?width=1200&height=800&fit=crop)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_15826.jpeg?width=1200&height=800&fit=crop)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://cdn.benzinga.com/files/images/story/2022/08/30/image-bed_bath__beyond.jpg?width=1200&height=800&fit=crop)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://cdn.benzinga.com/files/images/story/2022/08/29/image42.jpg?width=1200&height=800&fit=crop)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_14458.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/10/image31.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/09/image12_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_14378.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/09/image34_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/09/image41.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_14362.jpeg?width=1200&height=800&fit=crop)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Aytu BioPharma Announces Pricing of Public Offering
August 09, 2022
Via ACCESSWIRE
![](https://cdn.benzinga.com/files/images/story/2022/08/09/biotech7.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_14334.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-federal-hall.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/08/09/image_4.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_14317.jpeg?width=1200&height=800&fit=crop)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Aytu BioPharma Announces Launch of Public Offering
August 08, 2022
Via ACCESSWIRE
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_13814.jpeg?width=1200&height=800&fit=crop)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/10684.png?v=0)
From Aytu BioPharma, Inc.
Via AccessWire
![](https://cdn.benzinga.com/files/images/story/2022/07/20/bz-pharma_3.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/20/bz-pharma_1.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.